Dr. Jaime Imitola, chief of the Division of MS and Neuroimmunology at UConn Health, spoke on increasing public awareness of multiple sclerosis, particularly among minority demographics. Watch his presentation below:. via @neurology_live.

USC 2025 Multiple Sclerosis Retreat at Huntington Library. Our neurology faculty, research contributors, staff, undergraduates, and medical students pose for a group picture after a long day of learning!

ARHMS will engage with the community, scientists, patients, advocates and other stakeholders to improve research, awareness that are unmet needs in diverse MS. @TheGirlWithMS @mssociety @MSJ_Research.

ARHMS investigators across the US, have varied expertise in clinical care, epidemiology, genetics, imaging, immunology, and outcome measures and share a clear and unified vision to tackle MS in this community.

The Consortium will act to implement and strategically develop tools to examine MS outcomes and eventually evaluate treatment responses specific to this population.

The intention in a broad sense is to improve our understanding of this population epidemiologically and investigate its genetic contributions to disease and MS related progression.

ARHMS is intended to build collaborative partnerships with a broad group of clinicians and researchers that both care and treat Hispanic patients with MS and have a strong interest in research within this patient population.

The Alliance for Research in Hispanic MS (ARHMS) was formed to accelerate our understanding of multiple sclerosis across the Hispanic community.